 A multi-specialty telehealth platform provider, Hims Hers Health Inc NYSE: HIMS, reported Q2 sales increased 69 YY to 60.7 million, beating the consensus of 56.49 million. This was a quarter of very strong execution, as we continued to drive consistent organic revenue growth across our business, from our core categories to the newer mental health services, said Andrew Dudum, CEO and co-founder. 